Overactive bladder (OAB) syndrome with or without urinary incontinence is a prevalent condition with considerable cost to the individual and to the community. With our aging population the incidence is set to rise. However the current medical management has not really progressed with time as we are still using the derivatives of anticholinergic compounds for first line therapy. Clearly this is fertile soil for basic science research and to some extent, novel drug therapies are emerging targeting different symptom pathways. However patients failing conservative therapy are still considerable. Our understanding of the neural pathways is slowly paving the way for more effective strategies and minimally invasive techniques with nerve modulation are clearly an emerging modality. As our knowledge grows so will the options for wider therapeutics, which will enhance the quality of life of our patients. This chapter is by no means comprehensive but it aims to review the current data and gives a general overview to the current surgical management options available for our patients.
|Original language||English (US)|
|Title of host publication||Urinary Incontinence|
|Subtitle of host publication||Causes, Epidemiology and Treatment|
|Publisher||Nova Science Publishers, Inc.|
|Number of pages||16|
|State||Published - 2013|
ASJC Scopus subject areas